Biogen's total assets for Q3 2026 were $32.05B, a decrease of -0.10% from the previous quarter. CH:BIIB total liabilities were $13.13B for the fiscal quarter, a -0.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.